Showing results (1301-1310 of 1,566) with videos related to
Sort By:
Pageof 157
Gynecologic Oncology|March 25, 2023
Effect of bevacizumab in advanced low grade serous ovarian cancer: Data from the MITO 22 trialLucia Musacchio, Margherita Turinetto, Laura Arenare, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2020
Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK ActivationChao Liu, Sayed H Sadat, Koji Ebisumoto, et al.Diagnostics (Basel, Switzerland)|June 24, 2022
Prostate Cancer Diagnosis, Treatment and Outcomes in Patients with Previous or Synchronous Colorectal Cancer: A Systematic Review of Published EvidenceGiuseppe Celentano, Massimiliano Creta, Luigi Napolitano, et al.Bioinformatics (Oxford, England)|January 18, 2018
Splice Expression Variation Analysis (SEVA) for inter-tumor heterogeneity of gene isoform usage in cancerBahman Afsari, Theresa Guo, Michael Considine, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Short-term thalidomide incorporated into double autologous stem-cell transplantation improves outcomes in comparison with double autotransplantation for multiple myelomaMichele Cavo, Francesco Di Raimondo, Elena Zamagni, et al.Proceedings of the National Academy of Sciences of the United States of America|May 24, 2013
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesisAndrea Vecchione, Barbara Belletti, Francesca Lovat, et al.Cancer|March 18, 2015
Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancerTheresa Guo, Jesse R Qualliotine, Patrick K Ha, et al.Cancer Prevention Research (Philadelphia, Pa.)|May 12, 2011
NID2 and HOXA9 promoter hypermethylation as biomarkers for prevention and early detection in oral cavity squamous cell carcinoma tissues and salivaR Guerrero-Preston, E Soudry, J Acero, et al.European Journal of Cancer (Oxford, England : 1990)|April 15, 2014
Afatinib use in non-small cell lung cancer previously sensitive to epidermal growth factor receptor inhibitors: the United Kingdom Named Patient ProgrammeF Khan, C Ottensmeier, S Popat, et al.Oral Oncology|December 22, 2015
Cetuximab activity in dysplastic lesions of the upper aerodigestive tractZubair Khan, Joel B Epstein, Shanthi Marur, et al.Pageof 157